Field therapy in the treatment of actinic keratosis

Cutis

Volumn 93, Issue 4, 2014, Pages 172-173

  Perl, Marcel ^a   Goldenberg, Gary ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST OF ILLNESS; ECONOMICS; HUMAN; KERATOSIS, ACTINIC; PATHOLOGY; PATIENT PREFERENCE;

COST OF ILLNESS; HUMANS; KERATOSIS, ACTINIC; PATIENT PREFERENCE;

EID: 84898819395     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Neidecker MV, Davis-Ajami ML, Balkishnan R, et al. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics. 2009;27:451-464.
2. Krawtchenko N, Roewert-Huber J, Ulrich M, et al. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol. 2007;157(suppl 2):34-40.
3. Berman B, Cohen DE, Amini S. What is the role of field-directed therapy in the treatment of actinic keratosis? part 1: overview and investigational topical agents. Cutis. 2012;89:241-250.
4. Lebwohl M, Swanson N, Anderson LL, et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366:1010-1019.
5. Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response [published online ahead of print November 4, 2011]. J Am Acad Dermatol. 2012;66:486-493.
6. Data on file. Wilmington, MA: DUSA Pharmaceuticals, Inc; 2013.
7. Gupta AK, Paquet M, Villanueva E, et al. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;12:CD004415.
8. Wlodek C, Ali FR, Lear JT. Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients [published online ahead of print December 2, 2012]. Biomed Res Int. 2013;2013:349526.
9. Berman B, Amini S. Pharmacotherapy of actinic keratosis: an update. Expert Opin Pharmacother. 2012;13:1847-1871.
10. Samrao A, Cockerell CJ. Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents. Am J Clin Dermatol. 2013;14:273-277.
11. Anderson L, Schmieder GJ, Werschler WP, et al. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. J Am Acad Dermatol. 2009;60:934-943.
12. Gold MH. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses. J Drugs Dermatol. 2008;7:23-25.